Related Experiment Video
Updated: Jul 19, 2026
08:29
Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
Published on: December 18, 2016
[Neuropsychopatological factors on normal and pathological aging.].
Sante Mentale Au Quebec
|January 1, 1980
Summary
Aging impacts intelligence and memory due to brain changes, particularly in frontal and temporal regions. Distinguishing normal aging from cerebral organicity is crucial for effective therapy.
Area of Science:
- Neuropsychology
- Gerontology
- Cognitive Neuroscience
Context:
- Psychological characteristics of aging, specifically cognitive decline, warrant further investigation.
- Brain modifications in old age, including neuron loss, affect frontal and temporal regions.
- These changes impact mental flexibility, conceptualization, and memory functions.
Purpose:
- To explore the neuropsychological underpinnings of cognitive decline in aging.
- To differentiate between normal aging processes and cerebral organicity.
- To highlight the importance of accurate diagnosis for therapeutic interventions.
Summary:
- Neuron loss in aging primarily affects frontal and temporal brain regions.
- This fronto-temporal impact leads to reduced mental flexibility, increased rigidity in conceptual thinking, and impaired associative and organizational memory.
- Clinical diagnosis can be challenging due to overlapping affective and cognitive symptoms between normal aging and cerebral organicity.
Impact:
- Accurate diagnosis of cerebral organicity is essential for developing targeted therapies.
- Understanding the neuroanatomical basis of cognitive aging can inform interventions.
- Research emphasizes the need for precise diagnostic tools to guide treatment strategies for cognitive impairment in older adults.
Related Concept Videos
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:26Aging
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...